{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T16:27:16Z","timestamp":1786724836839,"version":"build-2736575974"},"reference-count":37,"publisher":"Oxford University Press (OUP)","issue":"4","license":[{"start":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T00:00:00Z","timestamp":1779926400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002996","name":"Dutch Heart Foundation","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100002996","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,7,4]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Atrial fibrillation (AF) and heart failure (HF) frequently coexist, and their combination is associated with poorer outcomes. The bidirectional risk and the impact of which disease develops first on mortality remain unclear.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We studied 31 374 UK Biobank participants with new-onset AF or HF (2006\u201322). Multivariable Cox models assessed risk factors, incidence, and mortality risk.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The risk of developing HF was higher in patients with AF than in those without AF (45.1 vs 3.87 per 1000 person-years; aHR 3.15, 95% CI 3.0\u20133.31). The risk of developing AF in patients with HF was higher than in those without HF (25.4 vs 2.27 per 1000 person-years; aHR 2.75, 95% CI 2.62\u20132.90). HF patients had a 31% higher risk of subsequent AF, compared with the risk of AF patients developing HF (P &amp;lt; .05). Mortality risk was substantially higher in patients with both conditions. AF before HF conferred a nearly four-fold increased risk (aHR 3.8, 95% CI 3.5\u20134.2), while HF before AF more than doubled risk (aHR 2.0, 95% CI 2.1\u20132.6), compared with either condition alone. Regardless of which disease was diagnosed first, there was no significant difference in mortality risk (aHR 0.95, 95% CI 0.85\u20131.07).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>AF and HF strongly predispose to each other, with HF conferring a higher relative risk for incident AF. The coexistence of both diseases substantially increases mortality regardless of which disease developed first, emphasizing the need for strategies to prevent the development of HF in patients with AF and vice versa.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/eschf\/xvag152","type":"journal-article","created":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T11:41:39Z","timestamp":1779882099000},"source":"Crossref","is-referenced-by-count":0,"title":["Development of atrial fibrillation in patients with heart failure and vice versa: incidence, risk factors, and their impact on survival"],"prefix":"10.1093","volume":"13","author":[{"given":"Arietje J L","family":"Zandijk","sequence":"first","affiliation":[{"name":"Department of Cardiology, University of Groningen, University Medical Center Groningen , Hanzeplein 1, Groningen 9713 GZ ,","place":["The Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hailun","family":"Qin","sequence":"additional","affiliation":[{"name":"Department of Cardiology, University of Groningen, University Medical Center Groningen , Hanzeplein 1, Groningen 9713 GZ ,","place":["The Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6043-0713","authenticated-orcid":false,"given":"Jasper","family":"Tromp","sequence":"additional","affiliation":[{"name":"Department of Cardiology, University of Groningen, University Medical Center Groningen , Groningen ,","place":["The Netherlands"]},{"name":"Saw Swee Hock School of Public Health, National University of Singapore and the National University Health System , Singapore ,","place":["Singapore"]},{"name":"National Heart Centre Singapore and Duke-NUS Medical School , Singapore ,","place":["Singapore"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2581-070X","authenticated-orcid":false,"given":"Michiel","family":"Rienstra","sequence":"additional","affiliation":[{"name":"Department of Cardiology, University of Groningen, University Medical Center Groningen , Hanzeplein 1, Groningen 9713 GZ ,","place":["The Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adriaan A","family":"Voors","sequence":"additional","affiliation":[{"name":"Department of Cardiology, University of Groningen, University Medical Center Groningen , Hanzeplein 1, Groningen 9713 GZ ,","place":["The Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,5,28]]},"reference":[{"key":"2026081410521899100_xvag152-B1","doi-asserted-by":"publisher","first-page":"2015","DOI":"10.1186\/s12889-022-14403-2","article-title":"Global, regional, and national burden of disease study of atrial fibrillation\/flutter, 1990\u20132019: results from a global burden of disease study, 2019","volume":"22","author":"Li","year":"2022","journal-title":"BMC Public Health"},{"key":"2026081410521899100_xvag152-B2","doi-asserted-by":"publisher","first-page":"3272","DOI":"10.1093\/cvr\/cvac013","article-title":"Global burden of heart failure: a comprehensive and updated review of epidemiology","volume":"118","author":"Savarese","year":"2023","journal-title":"Cardiovasc Res"},{"key":"2026081410521899100_xvag152-B3","doi-asserted-by":"publisher","first-page":"2982","DOI":"10.1016\/j.jacc.2020.11.010","article-title":"Global burden of cardiovascular diseases and risk factors, 1990\u20132019: update from the GBD 2019 study","volume":"76","author":"Roth","year":"2020","journal-title":"J Am Coll Cardiol"},{"key":"2026081410521899100_xvag152-B4","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1161\/CIRCULATIONAHA.115.018614","article-title":"Atrial fibrillation begets heart failure and vice versa: temporal associations and differences in preserved versus reduced ejection fraction","volume":"133","author":"Santhanakrishnan","year":"2016","journal-title":"Circulation"},{"key":"2026081410521899100_xvag152-B5","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1016\/j.mcna.2012.07.007","article-title":"Atrial fibrillation in heart failure","volume":"96","author":"Lardizabal","year":"2012","journal-title":"Med Clin North Am"},{"key":"2026081410521899100_xvag152-B6","doi-asserted-by":"publisher","first-page":"E153","DOI":"10.1161\/CIR.0000000000001052","article-title":"Heart disease and stroke statistics-2022 update: a report from the American Heart Association","volume":"145","author":"Tsao","year":"2022","journal-title":"Circulation"},{"key":"2026081410521899100_xvag152-B7","doi-asserted-by":"publisher","first-page":"1413","DOI":"10.1056\/nejmoa2022190","article-title":"Cardiovascular and renal outcomes with empagliflozin in heart failure","volume":"383","author":"Packer","year":"2020","journal-title":"N Engl J Med"},{"key":"2026081410521899100_xvag152-B8","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1002\/ejhf.187","article-title":"The prognostic significance of atrial fibrillation in heart failure with a preserved and reduced left ventricular function: insights from a meta-analysis","volume":"16","author":"Cheng","year":"2014","journal-title":"Eur J Heart Fail"},{"key":"2026081410521899100_xvag152-B9","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.hlpt.2012.07.003","article-title":"UK Biobank: current status and what it means for epidemiology","volume":"1","author":"Allen","year":"2012","journal-title":"Health Policy Technol"},{"key":"2026081410521899100_xvag152-B10","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1001779","article-title":"UK biobank: an open access resource for identifying the causes of a wide range of complex diseases of middle and old age","volume":"12","author":"Sudlow","year":"2015","journal-title":"PLoS Med"},{"key":"2026081410521899100_xvag152-B11","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1001\/jamacardio.2018.1717","article-title":"Associations of combined genetic and lifestyle risks with incident cardiovascular disease and diabetes in the UK biobank study","volume":"3","author":"Abdullah Said","year":"2018","journal-title":"JAMA Cardiol"},{"key":"2026081410521899100_xvag152-B12","doi-asserted-by":"publisher","first-page":"1592","DOI":"10.1093\/eurheartj\/ehaa1031","article-title":"Joint exposure to various ambient air pollutants and incident heart failure: a prospective analysis in UK Biobank","volume":"42","author":"Wang","year":"2021","journal-title":"Eur Heart J"},{"key":"2026081410521899100_xvag152-B13","doi-asserted-by":"publisher","first-page":"1592","DOI":"10.1093\/eurheartj\/ehaa1105","article-title":"Air pollution and flooding in the lungs: modern insights into ancient problems","volume":"42","author":"Rajagopalan","year":"2021","journal-title":"Eur Heart J"},{"key":"2026081410521899100_xvag152-B14","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0162388","article-title":"Algorithms for the capture and adjudication of prevalent and incident diabetes in UK Biobank","volume":"11","author":"Eastwood","year":"2016","journal-title":"PLoS One"},{"key":"2026081410521899100_xvag152-B15","doi-asserted-by":"publisher","first-page":"S14","DOI":"10.2337\/dc20-S002","article-title":"Classification and diagnosis of diabetes: Standards of Medical Care in Diabetes\u20142020","volume":"43","author":"American Diabetes Association","year":"2020","journal-title":"Diabetes Care"},{"key":"2026081410521899100_xvag152-B16","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1017\/s0047279400020341","article-title":"Deprivation","volume":"45","author":"Townsend","year":"1972","journal-title":"Health Visit"},{"key":"2026081410521899100_xvag152-B17","volume-title":"R: A Language and Environment for Statistical Computing","author":"R Core Team","year":"2021"},{"key":"2026081410521899100_xvag152-B18","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.ijcard.2021.07.006","article-title":"Association of heart failure subtypes and atrial fibrillation: data from the Atherosclerosis Risk in Communities (ARIC) study","volume":"339","author":"Nji","year":"2021","journal-title":"Int J Cardiol"},{"key":"2026081410521899100_xvag152-B19","doi-asserted-by":"publisher","first-page":"2920","DOI":"10.1161\/01.CIR.0000072767.89944.6E","article-title":"Temporal relations of atrial fibrillation and congestive heart failure and their joint influence on mortality: the Framingham Heart Study","volume":"107","author":"Wang","year":"2003","journal-title":"Circulation"},{"key":"2026081410521899100_xvag152-B20","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1016\/j.hrthm.2017.01.031","article-title":"No decline in the risk of heart failure after incident atrial fibrillation: a community study assessing trends overall and by ejection fraction","volume":"14","author":"Chamberlain","year":"2017","journal-title":"Heart Rhythm"},{"key":"2026081410521899100_xvag152-B21","doi-asserted-by":"publisher","first-page":"1807","DOI":"10.1016\/j.ijcard.2012.12.093","article-title":"Atrial fibrillation: profile and burden of an evolving epidemic in the 21st century","volume":"167","author":"Ball","year":"2013","journal-title":"Int J Cardiol"},{"key":"2026081410521899100_xvag152-B22","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1016\/j.jchf.2017.04.004","article-title":"Modifiable risk factors for incident heart failure in atrial fibrillation","volume":"5","author":"Chatterjee","year":"2017","journal-title":"JACC Heart Fail"},{"key":"2026081410521899100_xvag152-B23","doi-asserted-by":"publisher","first-page":"E347","DOI":"10.1161\/CIR.0000000000001209","article-title":"2024 heart disease and stroke statistics: a report of US and Global Data from the American Heart Association","volume":"149","author":"Martin","year":"2024","journal-title":"Circulation"},{"key":"2026081410521899100_xvag152-B24","doi-asserted-by":"publisher","first-page":"E1","DOI":"10.1161\/CIR.0000000000001193","article-title":"2023 ACC\/AHA\/ACCP\/HRS guideline for the diagnosis and management of atrial fibrillation: a report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines","volume":"149","author":"Joglar","year":"2024","journal-title":"Circulation"},{"key":"2026081410521899100_xvag152-B25","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1093\/europace\/euac186","article-title":"Atrial fibrillation onset before heart failure or vice versa: what is worst? A nationwide register study","volume":"25","author":"Pallisgaard","year":"2023","journal-title":"Europace"},{"key":"2026081410521899100_xvag152-B26","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1161\/CIRCHEARTFAILURE.111.962688","article-title":"Atrial fibrillation and mortality in heart failure: a community study","volume":"4","author":"Chamberlain","year":"2011","journal-title":"Circ Heart Fail"},{"key":"2026081410521899100_xvag152-B27","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1007\/s10985-013-9242-z","article-title":"On collapsibility and confounding bias in Cox and Aalen regression models","volume":"19","author":"Martinussen","year":"2013","journal-title":"Lifetime Data Anal"},{"key":"2026081410521899100_xvag152-B28","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.1161\/CIRCULATIONAHA.113.001475","article-title":"Temporal relationship and prognostic significance of atrial fibrillation in heart failure patients with preserved ejection fraction: a community-based study","volume":"128","author":"Zakeri","year":"2013","journal-title":"Circulation"},{"key":"2026081410521899100_xvag152-B29","doi-asserted-by":"publisher","first-page":"1997","DOI":"10.1016\/j.jacc.2006.01.060","article-title":"Atrial fibrillation and risk of clinical events in chronic heart failure with and without left ventricular systolic dysfunction","volume":"47","author":"Olsson","year":"2006","journal-title":"J Am Coll Cardiol"},{"key":"2026081410521899100_xvag152-B30","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1016\/j.jacep.2022.11.032","article-title":"Risks of heart failure, stroke, and bleeding in atrial fibrillation according to heart failure phenotypes","volume":"9","author":"Inciardi","year":"2023","journal-title":"JACC Clin Electrophysiol"},{"key":"2026081410521899100_xvag152-B31","doi-asserted-by":"publisher","first-page":"4285","DOI":"10.1093\/eurheartj\/ehy727","article-title":"Atrial fibrillation in heart failure syndromes: does it matter more in some than in others?","volume":"39","author":"Siontis","year":"2018","journal-title":"Eur Heart J"},{"key":"2026081410521899100_xvag152-B32","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1016\/j.ahj.2013.12.001","article-title":"Associations between atrial fibrillation and early outcomes of patients with heart failure and reduced or preserved ejection fraction","volume":"167","author":"Eapen","year":"2014","journal-title":"Am Heart J"},{"key":"2026081410521899100_xvag152-B33","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1016\/j.jchf.2017.05.001","article-title":"Atrial fibrillation in heart failure with preserved, mid-range, and reduced ejection fraction","volume":"5","author":"Sartipy","year":"2017","journal-title":"JACC Heart Fail"},{"key":"2026081410521899100_xvag152-B34","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1111\/jce.16209","article-title":"Atrial fibrillation and risk of adverse outcomes in heart failure with reduced, mildly reduced, and preserved ejection fraction: a systematic review and meta-analysis","volume":"35","author":"Kroshian","year":"2024","journal-title":"J Cardiovasc Electrophysiol"},{"key":"2026081410521899100_xvag152-B35","doi-asserted-by":"publisher","first-page":"932","DOI":"10.1016\/j.jacc.2023.12.033","article-title":"Implications of atrial fibrillation for guideline-directed therapy in patients with heart failure: JACC state-of-the-art review","volume":"83","author":"Newman","year":"2024","journal-title":"J Am Coll Cardiol"},{"key":"2026081410521899100_xvag152-B36","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1056\/nejmoa1707855","article-title":"Catheter ablation for atrial fibrillation with heart failure","volume":"378","author":"Marrouche","year":"2018","journal-title":"N Engl J Med"},{"key":"2026081410521899100_xvag152-B37","doi-asserted-by":"publisher","first-page":"1380","DOI":"10.1056\/nejmoa2306037","article-title":"Catheter ablation in end-stage heart failure with atrial fibrillation","volume":"389","author":"Sohns","year":"2023","journal-title":"N Engl J Med"}],"container-title":["ESC Heart Failure"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/eschf\/advance-article-pdf\/doi\/10.1093\/eschf\/xvag152\/68427042\/xvag152.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/eschf\/article-pdf\/13\/4\/xvag152\/68427042\/xvag152.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/eschf\/article-pdf\/13\/4\/xvag152\/68427042\/xvag152.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T15:28:44Z","timestamp":1786721324000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/eschf\/article\/doi\/10.1093\/eschf\/xvag152\/8697536"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,28]]},"references-count":37,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2026,5,28]]},"published-print":{"date-parts":[[2026,7,4]]}},"URL":"https:\/\/doi.org\/10.1093\/eschf\/xvag152","relation":{},"ISSN":["2055-5822"],"issn-type":[{"value":"2055-5822","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,8]]},"published":{"date-parts":[[2026,5,28]]},"article-number":"xvag152"}}